Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its…
Accelerating Connectivity in the Asia-Pacific: ADC Submarine Cable Empowers the Digital Future
HONG KONG, March 29, 2025 /PRNewswire/ -- On March 24, the launch…
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology…
China Telecom’s Asia Direct Cable (ADC) Capacity Enters Service Ahead of Schedule, Bolstering Regional Economic Development
HONG KONG, Feb. 14, 2025 /PRNewswire/ -- On February 14, 2025, China…
Shaurya Chakra Recipient Major Pradeep Arya Distributes Ration Kits in Ladakh, Jammu and Kashmir
NASSCOM Foundation, Bangalore, coordinated by its CEO Shri Ashok Pamidi and Infosys…
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers
January 21, 2025 19:00 ET | Source: ArriVent BioPharma, Inc. Exclusive global…
NextCure Announces Acceptance of IND Application for LNCB74
LNCB74 is a B7-H4-targeting antibody-drug conjugate being developed for multiple cancers in…